nadp has been researched along with Osteoporosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bujalska, IJ; Cooper, MS; Draper, N; Hewison, M; Lavery, GG; Stewart, PM; Tomlinson, JW; Walker, EA | 1 |
| Bujalska, I; Cooper, MS; Stewart, PM; Tomlinson, JW | 1 |
1 review(s) available for nadp and Osteoporosis
| Article | Year |
|---|---|
11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Amino Acid Sequence; Animals; Carbohydrate Dehydrogenases; Cloning, Molecular; Cortisone Reductase; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Glaucoma; Glucocorticoids; Humans; Hydrocortisone; Molecular Sequence Data; Mutation; NADP; Obesity; Organ Specificity; Osteoporosis; Recombinant Proteins; Sequence Alignment; Substrate Specificity; Transcription, Genetic | 2004 |
1 other study(ies) available for nadp and Osteoporosis
| Article | Year |
|---|---|
The role of 11 beta-hydroxysteroid dehydrogenase in central obesity and osteoporosis.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adipocytes; Bone and Bones; Cells, Cultured; Humans; Hydroxysteroid Dehydrogenases; Insulin-Like Growth Factor I; Isoenzymes; NADP; Obesity; Omentum; Osteoblasts; Osteoporosis; RNA, Messenger; Skin; Stem Cells; Tumor Necrosis Factor-alpha | 2000 |